Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en

Journal of Virology

Volumn 70, Issue 3, 1996, Pages 1818-1827

  Gubareva, L V ^a   Bethell, R ^b   Hart, G J ^b   Murti, K G ^a   Penn, C R ^b   Webstfr, R G ^a,c  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SIALIDASE INHIBITOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL AGGREGATION; ENZYME INHIBITION; GROWTH INHIBITION; INFLUENZA VIRUS A; NONHUMAN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; VIROGENESIS; VIRUS CHARACTERIZATION; VIRUS CULTURE; VIRUS MUTANT; VIRUS PLAQUE; VIRUS RESISTANCE;

EID: 0030028671     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.3.1818-1827.1996     Document Type: Article

References (34)

1. Appleyard, G. 1977. Amantadine-resistance as a genetic marker for influenza viruses. J. Gen. Virol. 36:249-255.
2. Aymard-Henry, M., M. T. Coleman, W. R. Dowdle, W. G. Laver, G. C. Schild, and R. G. Webster. 1973. Influenza virus neuramimdase-inhabitition test procedures. Buil. W. H. O. 48:199-202.
3. Bean, W. J., G. Sriram, and R. G. Webster. 1980. Electrophorctic analysis of iodine-labeled influenza virus RNA segments. Anal Biochem. 102:228-232
4. Bean, W. J., S. C. Threlkeld, and R. G. Webster. 1989. Biological potential of amantadine-resistant influenza A virus in an avian model. J. Infect. Dis 159:1050-1056.
5. Brand, C. M., and J. J. Skehel. 1972. Crystalline antigen from ihe influenza virus envelope. Nature (London) 238:366-373.
6. Burnet, F. M. 1948. Mucin and mucoids in relation to influenza virus action IV. Inhibition by purified mucoid of infection and haemagglutinin with the virus strain WSE. Aust. J. Exp. Biol. Med Sci 26:381-387
7. Cochran, K. W., H. F. Maassab, A. Tsunoda, and B. S. Berlin. 1965. Studies on the antiviral activity of amantadine hydrochloride. Ann. N Y. Acad Sci. 173:300-313.
8. Colman, P. M. 1989 Neuraminidase: enzyme and antigen. p 175-218. In R. M. Krug (ed). The influenza viruses. Plenum Press, NY
9. Colman, P. M. 1994. Influenza virus neuraminidase: structure. antibodies. and inhibitors. Protein Sci. 3:1687-1696. (Review.)
10. Colman, P. M., J. N. Varghese, and W. G. Laver. 1983. Structure of the catalytic and antigenic sites in influenza virus neuraminidase Nature (London) 303:41-44.
11. Dixon, M. 1953. The determination of enzyme inhibitor constants. Biochem J. 55:170-171.
12. Griffin, J. A., S. Basak, and R. W. Compans. 1983 Effect of hevose starvation and the role of sialic acid in influenza virus release Virology 125:324-334
13. Hart, G. J., and R. C. Bethell. 1995. 2,3-Didehydro-2,4-dideoxy-guanidino-N-acetyl-D-neuraminic acid (4-guanidino-Neu5Ac2en) is a slow, binding inhibitor of sialidase from both influenza A virus and influenza B virus. Biochem. Mol. Biol. Int 36:695-703.
14. Hayden, F. G., R. B. Belshe, R. D. Clover, A. J. Hay, M. G. Oakes, and W. Soo. 1989. Emergence and apparent transmission of rimandine-resistant influenza A virus in families N. Engl. J. Med. 321:1696-1702
15. Hayden, F. G., K. M. Cote, and R. G. Douglas, Jr. 1980. Ploquo inhibition assay for drug susceptibility testing of influenza viruses. Antimicrob Agents Chemother. 17:865-870.
16. Hayden, F. G., and R. B. Couch. 1993. Clinical and epidermological importance of influenza A viruses resistant to amantadine and rimantadine, p. 333-342. In C. Hannoun, A. P Kendal, H. D. Klenk, and F. L. Ruben (ed.), Options for the control of influenza II. Excerpta Medica, Amsterdam.
17. Holzer, C. T., M. von Itzstein, B. Jin, M. S. Pegg, W. P. Stewart, and W.-Y. Wu. 1993 Inhibition of sialidases from viral, bacterial and mammalian sources by analogues of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid modified at the C-4 position. Glycoconjugate J. 10:40-44.
18. Lakshmi, M. V., and I. T. Schulze, 1978. Effects of sialylation of influenza virions on their interactions with host cells and erythrocytes. Virology 88:314-324.
19. Liu, C., M. C. Eichelberger, R. W. Comparts, and G. M. Air. 1995. Influenza type A virus neurammidase does not play a role in viral entry, replication, assembly, or budding. J. Virol. 69:1099-1106.
20. Mast, E. E., M. W. Harmon, S. Gravenstein, S. Wu, N. H. Arden, R. Circo, G. Tjsika, A. P. Kendal, and J. P. Davis. 1991. Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreak of influenza A (H3N2). Am. J. Epidemiol. 134:988-997.
21. Matlin, K. S., H. Reggio, A. Helenius, and K. Simons. 1981. Infectious entry pathway of influenza virus in a canine kidney cell line. J. Cell Biol. 91:601-613
22. Oxford, J. S., L. S. Logan, and C. W. Potter. 1970. In vivo selection of an influenza A2 strain resistant to amantadine. Nature (London) 226:82-83.
23. Palese, P., and R. W. Compans. 1976. Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoro-acetyl-neuraminic acid (FANA): mechanism of action J. Gen. Virol 33:159-163.
24. Palese, P., and J. L. Schulman. 1977. Inhibitors of viral neuraminidase as potential antiviral drugs, p. 189-205. In J. S. Oxford (ed.), Chemoprophylaxis and virus infections of the respiratory tract. CRC Press. Inc, Cleveland.
25. Palese, P., K. Tobita, M. Ueda, and R. W. Compans. 1974. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 61:397-410
26. Parvin, J. D., A. Moscona, W. T. Pan, J. M. Leider, and P. Palese. 1986. Measurement of the mutation rates of animal viruses: influenza A virus and poliovirus type 1. J. Virol. 59:377-383.
27. Ryan, D. M., J. Ticehurst, M. H. Dempsey, and C. R. Penn. 1994. Inhibition of influenza virus replication in mice by GG167 (4-guanidmo-2,4-dideoxy-2,3-dehydro-N-acetylneurarminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase). Antimicrob. Agents Chemother. 38:2270-2275
28. Sauter, N. K., G. D. Click, R. L. Crowther, S.-J. Park, M. B. Eisen, J. J. Skehel, J. R. Knowles, and D. C. Wiley. 1992. Crystallographic detection of a second ligand binding site in influenza virus hemagglutinin Proc Natl. Acad. Sci. USA 89:324-328
29. Schild, G. C., J. S. Oxford, J. C. de Jong, and R. G. Webster. 1983. Evidence for host-cell selection of influenza virus antigenic variants Nature (London) 303:706-709.
30. Schulman, J. L., and P. Palese. 1975. Susceptibility of different strains of influenza A virus to the inhibitory effects of 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA). Virology 63:98-104
31. Thomas, G. P., M. Forsyth, C. R. Penn, and J. W. McCauley. 1994. Inhibition of the growth of influenza viruses in vitro by 4-guanidino-2,4-dideoxy-N-acetylneuraminic acid. Antivir. Res. 24:351-356.
32. von Itzstein, M., W.-Y. Wu, G. B. Kok, M. S. Pegg, J. C. Dyason, B. Jin, T. Van Phan, M. L. Smythe, H. F. White, S. W. Oliver, P. M. Colman, J. N. Varghese, D. M. Ryan, J. M. Woods, R. C. Bethell, V. J. Hotham, J. M. Cameron, and C. R. Penn. 1993. Rational design of potent sialidase-based inhibitors of influenza virus protection. Nature (London) 363:418-423.
33. Wilson, I. A., J. J. Skehel, and D. C. Wiley. 1981. Structure of the hemagglutinin membrane glycoprotein of influenza virus at 3Å resolution. Nature (London) 289:366-373.
34. Woods, J. M., R. C. Bethell, J. A. V. Coates, N. Healy, S. A. Hiscox, B. A. Pearson, D. M. Ryan, J. Ticehurst, J. Tilling, S. M. Walcott, and C. R. Penn. 1993. 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro. Antimicrob. Agents Chemother. 37:1473-1479.